Clariene SE (CLARI) | Stock Overview & Key Data
Clariene SE | Large-cap | Healthcare
Clariene SE | Large-cap | Healthcare
Clariene SE Performance Comparison
Stock Range
Today's Range
Low: €4.26
High: €4.45
on August 4, 2025
52 Week Range
Low: €1.49
High: €5.51
on October 17, 2024
on June 25, 2025
All-Time High: €7.80 on June 12, 2023
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€1.6B
EPS
-0.03
P/E Ratio (TTM)
9.76
Forward P/E
55.33
P/B Ratio
0.42
PEG Ratio
55.33
Div. Yield
N/A
ROE
-2.16%
Beta
0.868
Debt to Equity
209.68
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
4.71%
Profit Margin
-1.62%
Returns and Earnings
Return on Assets (TTM)
1.53%
Return on Equity (TTM)
-2.16%
EBITDA
€1.1B
Net Income (TTM)
€-85.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€14.91
Quarterly Revenue Growth (YoY)
1.10%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Clariene SE CLARI | 1.62B Large-cap | -10.69% | -14.97% | 13.59% | 96.02% | 106.05% | 146.11% | -42.09% | -42.09% |
| Emeis S.A EMEIS | 2.22B Large-cap | 18.55% | 24.34% | 12.16% | 106.62% | 125.99% | 36.44% | -99.12% | -99.80% |
| Orpea ORP | 1.96B Mid-cap | 18.55% | 24.34% | 12.16% | 106.62% | 125.99% | 36.44% | -99.12% | -99.80% |
| Ramsay Générale de GDS | 1.16B Large-cap | -2.34% | -4.13% | 7.51% | -2.34% | -18.36% | -31.92% | -51.17% | -38.89% |
| Lna Santé S.A LNA | 292.46M Mid-cap | 4.43% | 10.12% | 22.51% | 28.64% | 17.67% | 13.43% | -14.11% | -44.29% |
| EssilorLuxottica EL | 117.73B Large-cap | 2.24% | 8.68% | -0.85% | -3.30% | 9.01% | 22.50% | 59.41% | 133.58% |
Ownership & Short Interest
Insider Ownership
30.80%
Institutional Ownership
42.61%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
991K
Average 90-Day Volume
802K
Clariene SE Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Clariene SE would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CLARI's 52-week high and low?
- In the last 52 weeks, Clariene SE reached a high of €5.51 (on June 25, 2025) and a low of €1.49 (on October 17, 2024).
- What is the market cap and P/E ratio for CLARI?
- Curious about Clariene SE's size and valuation? Its market capitalization stands at 1.62B. When it comes to valuation, the P/E ratio (trailing twelve months) is 9.76, and the forward P/E (looking ahead) is 55.33.
- Does CLARI pay dividends? If so, what's the yield?
- As for dividends, Clariene SE isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Clariene SE's main competitors or similar companies to consider before investing?
When looking at Clariene SE, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Emeis S.A
EMEIS2.22B Healthcare Medical Care Facilities 36.44% -99.12% Orpea
ORP1.96B Healthcare Medical Care Facilities 36.44% -99.12% Ramsay Générale de
GDS1.16B Healthcare Medical Care Facilities -31.92% -51.17% Lna Santé S.A
LNA292.46M Healthcare Medical Care Facilities 13.43% -14.11% EssilorLuxottica
EL117.73B Healthcare Medical Instruments & Supplies 22.50% 59.41% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Clariene SE? (e.g., ROE, Debt/Equity)
- To get a sense of Clariene SE's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -2.16%, the Debt to Equity ratio from the most recent quarter is 209.68, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for CLARI?
- Looking at Clariene SE's growth, its revenue over the trailing twelve months (TTM) was €5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 1.10%, and quarterly earnings saw a YoY growth of N/A.
- How much of CLARI stock is held by insiders and institutions?
- Wondering who owns Clariene SE stock? Company insiders (like executives and directors) hold about 30.80% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 42.61%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.